Eisai is to suspend commercial distribution of its new epilepsy drug Fycompa in Germany, noting that they continue to disagree with the country’s reimbursement regulatory body’s rejection of the therapy. In March, the German Federal Joint Committee declared that they consider the additional benefit of Fycompa unproven when compared to two other treatments – GlaxoSmithKline’s
Clinical Professionals London office move to Bouverie Street Come Friday May 24th, Clinical Professionals London office is moving from its current location in its offices in Quantum House, to 11-12 Bouverie Street. This move will more than double the office space from 700sq ft, to a new much bigger environment of 1,600sq ft – a significant improvement.
Bayer’s chief executive, Marijn Dekkers (pictured), has expressed concern around the pricing squeeze being placed on innovative pharmaceutical groups, whose efforts, he believes, are greatly under-appreciated by society. Speaking at Bayer’s annual press conference in Leverkusen, Dr Dekkers commented that it is “crucial to have an environment that views innovation as something desirable and values
Although healthcare related topics are one of the top search categories online, pharmaceuticals are not leveraging the potential of the World Wide Web, Jens Monsees, industry head, consumer goods and healthcare at Google, said. Monsees added that there are several areas where pharma is falling short in optimising their presence online. He noted that pharmaceutical